Flunarizine in pharma franchise in Andhra Pradesh

Flunarizine in PCD pharma franchise in Agartala

Flunarizine in top pharma company in Patna

Flunarizine in pcd pharma supplier in Bhubaneswar

Flunarizine in phama franchise company in India
Flunarizine in phama distributor in Udupi

Home/Products /flunarizine-5mg-tablet

Flunafeb 5 Tablet

Composition : Flunarizine (5mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹32/-

Flunafeb 5 Tablet is a calcium channel blocker that effectively aids in preventing migraines and managing vestibular disorders like vertigo. By limiting the excessive calcium influx in brain cells, Flunarizine helps stabilize neuronal activity, which is often disrupted during migraine episodes. This mechanism reduces the frequency, severity, and duration of migraines, making it an essential choice for prophylactic migraine management.

This formulation also improves blood flow to the brain, alleviating symptoms such as dizziness, nausea, and imbalance commonly associated with vestibular disorders. It is particularly suitable for individuals seeking to control chronic migraines or vertigo symptoms and works best when integrated into a preventive treatment plan under medical supervision.

Flunafeb 5 Tablet is typically prescribed as a low-dose option for gradual symptom control and is best taken at bedtime to minimize potential drowsiness. With its well-tolerated profile and efficacy, it enhances the patient’s quality of life by mitigating symptoms that hinder daily functioning.

Read More

About the Product

Flunafeb 5 Tablet is a calcium channel blocker that effectively aids in preventing migraines and managing vestibular disorders like vertigo. By limiting the excessive calcium influx in brain cells, Flunarizine helps stabilize neuronal activity, which is often disrupted during migraine episodes. This mechanism reduces the frequency, severity, and duration of migraines, making it an essential choice for prophylactic migraine management.

This formulation also improves blood flow to the brain, alleviating symptoms such as dizziness, nausea, and imbalance commonly associated with vestibular disorders. It is particularly suitable for individuals seeking to control chronic migraines or vertigo symptoms and works best when integrated into a preventive treatment plan under medical supervision.

Flunafeb 5 Tablet is typically prescribed as a low-dose option for gradual symptom control and is best taken at bedtime to minimize potential drowsiness. With its well-tolerated profile and efficacy, it enhances the patient’s quality of life by mitigating symptoms that hinder daily functioning.

Common side effects include drowsiness, fatigue, increased appetite, weight gain, and occasional dry mouth. Rare side effects might include depression, tremors, or movement disorders.

Flunafeb 5 Tablet is indicated for the prevention of migraines and the treatment of vertigo associated with vestibular disorders.

Flunafeb 5 Tablet should be used under medical supervision. Avoid alcohol or tasks requiring alertness, such as driving, if drowsiness occurs. Report any adverse effects or unusual symptoms to your healthcare provider immediately.

Store in a cool, dry place away from direct sunlight and moisture. Keep the medication out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation